Does the teratogenicity of isotretinoin outweigh its benefits?
Publication
, Journal Article
Jordan, AY; Parks, L; Chen, SC; Higgins, K; Fleischer, AB; Feldman, SR
Published in: J Dermatolog Treat
2005
Duke Scholars
Published In
J Dermatolog Treat
DOI
ISSN
0954-6634
Publication Date
2005
Volume
16
Issue
4
Start / End Page
190 / 192
Location
England
Related Subject Headings
- Quality-Adjusted Life Years
- Quality of Life
- Pregnancy
- Isotretinoin
- Humans
- Female
- Dermatology & Venereal Diseases
- Dermatologic Agents
- Acne Vulgaris
- Abnormalities, Drug-Induced
Citation
APA
Chicago
ICMJE
MLA
NLM
Jordan, A. Y., Parks, L., Chen, S. C., Higgins, K., Fleischer, A. B., & Feldman, S. R. (2005). Does the teratogenicity of isotretinoin outweigh its benefits? J Dermatolog Treat, 16(4), 190–192. https://doi.org/10.1080/09546630510044904
Jordan, Amy Y., Lauren Parks, Suephy C. Chen, Kristen Higgins, Alan B. Fleischer, and Steven R. Feldman. “Does the teratogenicity of isotretinoin outweigh its benefits?” J Dermatolog Treat 16, no. 4 (2005): 190–92. https://doi.org/10.1080/09546630510044904.
Jordan AY, Parks L, Chen SC, Higgins K, Fleischer AB, Feldman SR. Does the teratogenicity of isotretinoin outweigh its benefits? J Dermatolog Treat. 2005;16(4):190–2.
Jordan, Amy Y., et al. “Does the teratogenicity of isotretinoin outweigh its benefits?” J Dermatolog Treat, vol. 16, no. 4, 2005, pp. 190–92. Pubmed, doi:10.1080/09546630510044904.
Jordan AY, Parks L, Chen SC, Higgins K, Fleischer AB, Feldman SR. Does the teratogenicity of isotretinoin outweigh its benefits? J Dermatolog Treat. 2005;16(4):190–192.
Published In
J Dermatolog Treat
DOI
ISSN
0954-6634
Publication Date
2005
Volume
16
Issue
4
Start / End Page
190 / 192
Location
England
Related Subject Headings
- Quality-Adjusted Life Years
- Quality of Life
- Pregnancy
- Isotretinoin
- Humans
- Female
- Dermatology & Venereal Diseases
- Dermatologic Agents
- Acne Vulgaris
- Abnormalities, Drug-Induced